Significant differences between vascular and nonvascular surgeons in the perioperative management of antiplatelet therapies in patients with coronary stents

Annals of Vascular Surgery

Volumn 29, Issue 3, 2015, Pages 526-533.e2

  Kilic, Arman ^a   Sultan, Ibrahim S ^a   Arnaoutakis, George J ^a   Black, James H ^a   Reifsnyder, Thomas ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; METAL;

ARTICLE; BARE METAL STENT; BLEEDING; BLEEDING RISK; DRUG ELUTING STENT; HEALTH SURVEY; HUMAN; NONVASCULAR SURGEON; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SURGEON; VASCULAR SURGEON; WORK EXPERIENCE; ADVERSE EFFECTS; BLOOD LOSS, SURGICAL; CHEMICALLY INDUCED; CLINICAL PRACTICE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DEVICES; DRUG ADMINISTRATION; HEALTH CARE SURVEY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PROSTHESIS DESIGN; QUESTIONNAIRE; RISK FACTOR; SPECIALIZATION; STENT; SURGERY; TRENDS;

BLOOD LOSS, SURGICAL; CORONARY ARTERY DISEASE; DRUG ADMINISTRATION SCHEDULE; DRUG-ELUTING STENTS; HEALTH CARE SURVEYS; HUMANS; METALS; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PRACTICE PATTERNS, PHYSICIANS'; PROSTHESIS DESIGN; RISK FACTORS; SPECIALIZATION; STENTS; SURGEONS; SURGICAL PROCEDURES, OPERATIVE; SURVEYS AND QUESTIONNAIRES;

EID: 84924913770     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2014.09.031     Document Type: Article

References (15)

1. U. Sigwart, J. Puel, and V. Mirkovitch Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty N Engl J Med 316 1987 701 706
2. A.J. Epstein, D. Polsky, and F. Yang Coronary revascularization trends in the United States, 2001-2008 JAMA 305 2011 1769 1776
3. S.H. Wilson, C.S. Rihal, and M.R. Bell Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin Am J Cardiol 83 1999 1006 1011
4. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
5. T.T. Tsai, P.M. Ho, and S. Xu Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent) Circ Cardiovasc Interv 3 2010 230 235
6. G. De Berardis, G. Lucisano, and A. D'Ettorre Association of aspirin use with major bleeding in patients with and without diabetes JAMA 307 2012 2286 2294
7. R.W. Yeh, S. Sidney, and M. Chandra Population trends in the incidence and outcomes of acute myocardial infarction N Engl J Med 362 2010 2155 2165
8. K. Andersen, B.K. Johannesdottir, and J.M. Kristjansson Decreasing case fatality in myocardial infarction is explained by improved medical treatment Acta Cardiol 66 2011 39 45
9. P.B. Berger, N.S. Kleiman, and M.J. Pencina Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry JACC Cardiovasc Interv 3 2010 920 927
10. N.L. Cruden, S.A. Harding, and A.D. Flapan Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery Circ Cardiovasc Interv 3 2010 236 242
11. P. Albaladejo, E. Marret, and C.M. Samama Non-cardiac surgery in patients with coronary stents: the RECO study Heart 97 2011 1566 1572
12. W. Burger, J.M. Chemnitius, and G.D. Kneissl Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis J Intern Med 257 2005 399 414
13. PEP trial group Prevention of pulmonary embolism and deep vein thrombosis with low-dose aspirin: Pulmonary Embolism Prevention (PEP) trial Lancet 355 2000 1295 1302
14. J. Mantz, C.M. Samama, and F. Tubach Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial Br J Anaesth 107 2011 899 910
15. S. Darvish-Kazem, M. Gandhi, and M. Marcucci Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: a systematic review of clinical practice guidelines Chest 144 2013 1848 1856